Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #251 to #500.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Clearance level‏‎ (2 revisions)
  2. Worker‏‎ (2 revisions)
  3. Nuclear track detectors‏‎ (2 revisions)
  4. Radiation safety officer‏‎ (2 revisions)
  5. Dose conversion coefficient‏‎ (2 revisions)
  6. Radiosensitiser‏‎ (2 revisions)
  7. Edema‏‎ (2 revisions)
  8. Rehabilitation of living conditions‏‎ (2 revisions)
  9. Excess relative risk‏‎ (2 revisions)
  10. Right to know‏‎ (2 revisions)
  11. Exposure situation‏‎ (2 revisions)
  12. Incidence‏‎ (2 revisions)
  13. Solar wind‏‎ (2 revisions)
  14. Growth factor‏‎ (2 revisions)
  15. Alimentary tract transfer factor‏‎ (2 revisions)
  16. Target tissue‏‎ (2 revisions)
  17. Beta-plus decay‏‎ (2 revisions)
  18. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  19. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  20. Working level‏‎ (2 revisions)
  21. OLINDA/EXM‏‎ (2 revisions)
  22. Particle radiance‏‎ (2 revisions)
  23. Cumulative dose‏‎ (2 revisions)
  24. Protection strategy‏‎ (2 revisions)
  25. Radiation source‏‎ (2 revisions)
  26. Radiosensitivity, cellular‏‎ (2 revisions)
  27. Effect Dose 50‏‎ (2 revisions)
  28. Endogeneous excretion‏‎ (2 revisions)
  29. Rigidity‏‎ (2 revisions)
  30. Exposure to Radon at Home‏‎ (2 revisions)
  31. Security‏‎ (2 revisions)
  32. Incident‏‎ (2 revisions)
  33. GATA binding protein 2‏‎ (2 revisions)
  34. Intermediate level waste‏‎ (2 revisions)
  35. Stenosis‏‎ (2 revisions)
  36. Hormones‏‎ (2 revisions)
  37. Authorization‏‎ (2 revisions)
  38. Local DRL‏‎ (2 revisions)
  39. Tolerability‏‎ (2 revisions)
  40. Medical exposure‏‎ (2 revisions)
  41. Naturally occurring radioactive material‏‎ (2 revisions)
  42. Clonogenic cells‏‎ (2 revisions)
  43. Working level month‏‎ (2 revisions)
  44. Curie‏‎ (2 revisions)
  45. Inclusiveness‏‎ (2 revisions)
  46. Acute radiation syndrome‏‎ (2 revisions)
  47. Source-related‏‎ (2 revisions)
  48. Internal conversion electron‏‎ (2 revisions)
  49. LD 50/30‏‎ (2 revisions)
  50. Hounsfield unit‏‎ (2 revisions)
  51. Authorized limit‏‎ (2 revisions)
  52. Telangiectasia‏‎ (2 revisions)
  53. Member of the public‏‎ (2 revisions)
  54. Cardiac arrhythmias‏‎ (2 revisions)
  55. Unattached fraction‏‎ (2 revisions)
  56. Necrosis‏‎ (2 revisions)
  57. Clonogenic survival‏‎ (2 revisions)
  58. Patient entrance reference point‏‎ (2 revisions)
  59. Cytokines‏‎ (2 revisions)
  60. Potential recoverability correction factor‏‎ (2 revisions)
  61. Protective action guide‏‎ (2 revisions)
  62. Radiation worker‏‎ (2 revisions)
  63. Dose criteria‏‎ (2 revisions)
  64. Radon: Units of Measure‏‎ (2 revisions)
  65. Reference air kerma‏‎ (2 revisions)
  66. Environmental exposure‏‎ (2 revisions)
  67. Exempt waste‏‎ (2 revisions)
  68. Self-help protection‏‎ (2 revisions)
  69. Individual-related‏‎ (2 revisions)
  70. Adaptive response‏‎ (2 revisions)
  71. Alveolar-interstitial region‏‎ (2 revisions)
  72. Storage‏‎ (2 revisions)
  73. Autoimmune disease‏‎ (2 revisions)
  74. Track structure‏‎ (2 revisions)
  75. Mendelian diseases‏‎ (2 revisions)
  76. ICRP Publication 118‏‎ (2 revisions)
  77. Cardiac valve diseases‏‎ (2 revisions)
  78. Neurological syndrome‏‎ (2 revisions)
  79. Occupational exposure‏‎ (2 revisions)
  80. Peak skin dose‏‎ (2 revisions)
  81. Disposal‏‎ (2 revisions)
  82. Radioactive dispersion device‏‎ (2 revisions)
  83. Environmental radiation protection‏‎ (2 revisions)
  84. Exemption level‏‎ (2 revisions)
  85. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  86. Individual decontamination‏‎ (2 revisions)
  87. Subcutaneous tissue‏‎ (2 revisions)
  88. Low dose rate‏‎ (2 revisions)
  89. Transfer compartment‏‎ (2 revisions)
  90. Mitigation‏‎ (2 revisions)
  91. Upper reference levels‏‎ (2 revisions)
  92. Neurovascular syndrome‏‎ (2 revisions)
  93. Co-expertise‏‎ (2 revisions)
  94. Connective tissue‏‎ (2 revisions)
  95. Pelagic‏‎ (2 revisions)
  96. DRL process‏‎ (2 revisions)
  97. Practical radiological protection culture‏‎ (2 revisions)
  98. Radioactive source‏‎ (2 revisions)
  99. Effective dose equivalent‏‎ (2 revisions)
  100. Reference biokinetic model‏‎ (2 revisions)
  101. Relocation‏‎ (2 revisions)
  102. Existing exposure situation‏‎ (2 revisions)
  103. Risk coefficient‏‎ (2 revisions)
  104. Individual monitoring‏‎ (2 revisions)
  105. Gastroschisis‏‎ (2 revisions)
  106. Source term‏‎ (2 revisions)
  107. Angiogenesis‏‎ (2 revisions)
  108. Latent time/period or latency interval‏‎ (2 revisions)
  109. Hyperbaric oxygen‏‎ (2 revisions)
  110. Low level waste‏‎ (2 revisions)
  111. Bioturbation‏‎ (2 revisions)
  112. Cardioverter-defibrillator‏‎ (2 revisions)
  113. Consequential late effects‏‎ (2 revisions)
  114. Qualified expert‏‎ (2 revisions)
  115. Radioactive substance‏‎ (2 revisions)
  116. Radon Recommendations for Authorities‏‎ (2 revisions)
  117. Reference individual‏‎ (2 revisions)
  118. Epithelium‏‎ (2 revisions)
  119. Remedial action‏‎ (2 revisions)
  120. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  121. Acceptance test‏‎ (2 revisions)
  122. Gastrulation‏‎ (2 revisions)
  123. Intervention Level‏‎ (2 revisions)
  124. Habitual mouth breather‏‎ (2 revisions)
  125. Annihilation photons‏‎ (2 revisions)
  126. Substantial radiation dose level‏‎ (2 revisions)
  127. Hyperfractionation‏‎ (2 revisions)
  128. Bone marrow‏‎ (2 revisions)
  129. Transfer rate‏‎ (2 revisions)
  130. Multi-detector computed tomography‏‎ (2 revisions)
  131. Cohort study‏‎ (2 revisions)
  132. Percutaneous coronary intervention‏‎ (2 revisions)
  133. DRL value‏‎ (2 revisions)
  134. Prevailing circumstances‏‎ (2 revisions)
  135. Radon Recommendations for Workplaces‏‎ (2 revisions)
  136. Reference level‏‎ (2 revisions)
  137. Equieffective dose‏‎ (2 revisions)
  138. Remediation‏‎ (2 revisions)
  139. Expanded and aligned radiation field‏‎ (2 revisions)
  140. Risk of Exposure to Radon‏‎ (2 revisions)
  141. Adventitious‏‎ (2 revisions)
  142. South Atlantic anomaly‏‎ (2 revisions)
  143. Interventional procedure‏‎ (2 revisions)
  144. Habitual nose breather‏‎ (2 revisions)
  145. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  146. Background dose (rate)‏‎ (2 revisions)
  147. Lymphatic system‏‎ (2 revisions)
  148. Transforming growth factor‏‎ (2 revisions)
  149. Containment‏‎ (2 revisions)
  150. Pericarditis‏‎ (2 revisions)
  151. Principle of application of dose limits‏‎ (2 revisions)
  152. Dose-length product‏‎ (2 revisions)
  153. Radioactivity‏‎ (2 revisions)
  154. Electron-capture decay‏‎ (2 revisions)
  155. Repopulation‏‎ (2 revisions)
  156. Routine monitoring‏‎ (2 revisions)
  157. ICRPædia Guide to Radon‏‎ (2 revisions)
  158. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  159. Special (non-routine) monitoring‏‎ (2 revisions)
  160. Lifetime risk‏‎ (2 revisions)
  161. Hypoplasia‏‎ (2 revisions)
  162. Backscatter detection system‏‎ (2 revisions)
  163. Macrophage colony stimulating factor‏‎ (2 revisions)
  164. Bradycardia‏‎ (2 revisions)
  165. Multiplicative risk projection model‏‎ (2 revisions)
  166. Detriment‏‎ (2 revisions)
  167. Dose-rate effect‏‎ (2 revisions)
  168. Dose of record Hp (10)‏‎ (2 revisions)
  169. Electrophysiology‏‎ (2 revisions)
  170. Representative organism (non-human biota)‏‎ (2 revisions)
  171. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  172. Accreditation‏‎ (2 revisions)
  173. Genomic integrity‏‎ (2 revisions)
  174. Hazard‏‎ (2 revisions)
  175. Threshold dose for tissue reactions‏‎ (2 revisions)
  176. Magnetosphere‏‎ (2 revisions)
  177. Bragg peak‏‎ (2 revisions)
  178. Coronary heart disease‏‎ (2 revisions)
  179. Decay constant‏‎ (2 revisions)
  180. Radiographer‏‎ (2 revisions)
  181. Representative person‏‎ (2 revisions)
  182. Safety‏‎ (2 revisions)
  183. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  184. Action Level‏‎ (2 revisions)
  185. Specific effective energy‏‎ (2 revisions)
  186. Health Surveillance‏‎ (2 revisions)
  187. Limitation of dose‏‎ (2 revisions)
  188. Basal cell‏‎ (2 revisions)
  189. Branching fraction‏‎ (2 revisions)
  190. Transmission detection system‏‎ (2 revisions)
  191. Multistage tumorigenesis‏‎ (2 revisions)
  192. Chronic exposure‏‎ (2 revisions)
  193. Non-sphericity parameter‏‎ (2 revisions)
  194. Colony‏‎ (2 revisions)
  195. Cosmic Radiation in Aviation‏‎ (2 revisions)
  196. Pharynx‏‎ (2 revisions)
  197. Decommissioning‏‎ (2 revisions)
  198. Dose-threshold‏‎ (2 revisions)
  199. ICRP Publication 5‏‎ (1 revision)
  200. Dose-threshold hypothesis‏‎ (1 revision)
  201. Radiological attack‏‎ (1 revision)
  202. ICRP Publication 64‏‎ (1 revision)
  203. Reactive oxygen species‏‎ (1 revision)
  204. ICRP Publication 79‏‎ (1 revision)
  205. Reference worker‏‎ (1 revision)
  206. ICRP Publication 92‏‎ (1 revision)
  207. 1956 Recommendations‏‎ (1 revision)
  208. Activation‏‎ (1 revision)
  209. Informed consent‏‎ (1 revision)
  210. Spongiosa‏‎ (1 revision)
  211. ICRP Publication 1‏‎ (1 revision)
  212. Baseline disease rates‏‎ (1 revision)
  213. Marrow cellularity‏‎ (1 revision)
  214. ICRP Publication 110‏‎ (1 revision)
  215. Breakpoint cluster region/abelson‏‎ (1 revision)
  216. Multitarget equation‏‎ (1 revision)
  217. ICRP Publication 125‏‎ (1 revision)
  218. ICRP Publication 14‏‎ (1 revision)
  219. Commissioning‏‎ (1 revision)
  220. ICRP Publication 154‏‎ (1 revision)
  221. Cosmic radiation‏‎ (1 revision)
  222. Pilomatricoma‏‎ (1 revision)
  223. ICRP Publication 29‏‎ (1 revision)
  224. ICRP Publication 35‏‎ (1 revision)
  225. Radiation-induced secondary malignancy‏‎ (1 revision)
  226. ICRP Publication 50‏‎ (1 revision)
  227. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  228. Radiological controlled area‏‎ (1 revision)
  229. ICRP Publication 65‏‎ (1 revision)
  230. ICRP Publication 8‏‎ (1 revision)
  231. Referrer‏‎ (1 revision)
  232. ICRP Publication 93‏‎ (1 revision)
  233. 1959 Decisions‏‎ (1 revision)
  234. ICRU 4-element tissue‏‎ (1 revision)
  235. Hereditary effect‏‎ (1 revision)
  236. System of radiological protection‏‎ (1 revision)
  237. ICRP Publication 10‏‎ (1 revision)
  238. Time-resolved computed tomography‏‎ (1 revision)
  239. ICRP Publication 111‏‎ (1 revision)
  240. Mutation component‏‎ (1 revision)
  241. ICRP Publication 126‏‎ (1 revision)
  242. Waste management‏‎ (1 revision)
  243. Normal tissue complication probability‏‎ (1 revision)
  244. ICRP Publication 140‏‎ (1 revision)
  245. ICRP Publication 155‏‎ (1 revision)
  246. ICRP Publication 3‏‎ (1 revision)
  247. ICRP Publication 36‏‎ (1 revision)
  248. Dicentric chromosome‏‎ (1 revision)
  249. ICRP Publication 51‏‎ (1 revision)
  250. ICRP Publication 66‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"